pyrrolidine dithiocarbamate has been researched along with Cardiac Hypertrophy in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Fang, XL; Hong, HQ; Liu, PQ; Lu, J; Ye, JT; Yuan, J; Zhang, YH | 1 |
| Chen, W; Cui, W; Jia, LL; Kang, YM; Qi, J; Qin, DN; Song, XA; Tan, H; Yu, XJ; Zhang, DM; Zhu, GQ | 1 |
| Gupta, S; Sen, S; Young, D | 1 |
| Roy, S; Sen, CK | 1 |
| Browder, IW; Gao, X; Ha, T; Haddad, GE; Izumo, S; Kao, RL; Kelley, JL; Li, C; Li, Y; McMullen, JR; Shioi, T; Williams, DL; Zhao, A | 1 |
1 review(s) available for pyrrolidine dithiocarbamate and Cardiac Hypertrophy
| Article | Year |
|---|---|
Relief from a heavy heart: redox-sensitive NF-kappaB as a therapeutic target in managing cardiac hypertrophy.
Topics: Animals; Antioxidants; Cardiomegaly; Humans; NF-kappa B; Oxidation-Reduction; Pyrrolidines; Thiocarbamates | 2005 |
4 other study(ies) available for pyrrolidine dithiocarbamate and Cardiac Hypertrophy
| Article | Year |
|---|---|
G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway.
Topics: Animals; Cardiomegaly; Cell Nucleus; Disease Models, Animal; Gene Knockdown Techniques; GTP-Binding Protein Regulators; Isoproterenol; Male; Myocytes, Cardiac; NF-kappa B; NF-KappaB Inhibitor alpha; Pyrrolidines; Rats, Sprague-Dawley; RNA-Binding Proteins; RNA, Messenger; Signal Transduction; Thiocarbamates; Transcription Factor RelA | 2018 |
Inhibition of NF-κB activity in the hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by modulating cytokines and attenuating oxidative stress.
Topics: Animals; Arterial Pressure; Biomarkers; Cardiomegaly; Cytokines; Disease Models, Animal; Hypertension; Inflammation Mediators; Oxidative Stress; Paraventricular Hypothalamic Nucleus; Pyrrolidines; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Sympathetic Nervous System; Thiocarbamates; Time Factors; Transcription Factor RelA | 2015 |
Inhibition of NF-kappaB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cardiomegaly; Disease Progression; Hydralazine; Hypertension; I-kappa B Proteins; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Organ Size; Pyrrolidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Thiocarbamates; Vasodilator Agents | 2005 |
Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivo.
Topics: Animals; Antioxidants; Body Weight; Cardiomegaly; Disease Models, Animal; Dose-Response Relationship, Drug; Mice; Mice, Transgenic; NF-kappa B; Organ Size; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinases; Proto-Oncogene Proteins c-akt; Pyrrolidines; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; Thiocarbamates; TOR Serine-Threonine Kinases | 2005 |